The role of atypical protein kinase C in CSF-1-dependent Erk activation and proliferation in myeloid progenitors and macrophages

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Lee, Angel W ^a,b,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c OncProTech   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

A RAF KINASE; COLONY STIMULATING FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN KINASE C ZETA; RAS PROTEIN; DRUG DERIVATIVE; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOLOL MYRISTATE ACETATE; PKC 3 PROTEIN; PKC-3 PROTEIN; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR; RAF PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; MACROPHAGE; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; BONE MARROW CELL; CELL LINE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; MITOSIS; PHOSPHORYLATION;

MURINAE;

ANIMALS; BONE MARROW CELLS; CELL LINE; CELL PROLIFERATION; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; MITOSIS; MYELOID PROGENITOR CELLS; NF-KAPPA B; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS A-RAF; PROTO-ONCOGENE PROTEINS C-RAF; TETRADECANOYLPHORBOL ACETATE; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80054716826     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025580     Document Type: Article

References (58)

1. Pixley FJ, Stanley ER, (2004) CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol 14: 628-638.
2. Chitu V, Stanley ER, (2006) Colony-stimulating factor-1 in immunity and inflammation. Curr Opin Immunol 18: 39-48.
3. Kacinski BM, (1997) CSF-1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract. Mol Reprod Dev 46: 71-74.
4. Lin H, Lee E, Hestir K, Leo C, Huang M, et al. (2008) Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 320: 807-811.
5. Wei S, Nandi S, Chitu V, Yeung Y-G, Yu W, et al. (2010) Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells. J Leukoc Biol 88: 495-505.
6. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, et al. (2010) Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330: 841-845.
7. Lee AW-M, Nienhuis A, (1990) Mechanism of kinase activation in the receptor for colony-stimulating factor 1. Proc Natl Acad Sci USA 87: 7270-7274.
8. Ohtsuka M, Roussel M, Sherr CJ, (1990) Ligand-induced phosphorylation of the colony-stimulating factor 1 receptor can occur through an intermolecular reaction that triggers receptor down modulation. Mol Cell Biol 10: 1664-1671.
9. Hunter M, Wang Y, Eubank T, Baran C, Nana-Sinkam P, et al. (2009) Survival of monocytes and macrophages and their role in health and disease. Front Biosci 14: 4079-4102.
10. Rohde CM, Schrum J, Lee AW-M, (2004) A Juxtamembrane Tyrosine in the Colony Stimulating Factor-1 Receptor Regulates Ligand-induced Src Association, Receptor Kinase Function, and Down-regulation. J Biol Chem 279: 43448-43461.
11. Xiong Y, Song D, Cai Y, Yu W, Yeung YG, et al. (2011) A CSF-1 receptor phosphotyrosine 559 signaling pathway regulates receptor ubiquitination and tyrosine phosphorylation. J Biol Chem 286: 952-960.
12. van der Geer P, Hunter T, (1993) Mutation of Tyr697, a Grb2-binding site, and Tyr721, a PI 3-kinase binding site, abrogates signal transduction by the murine CSF-1 receptor expressed in Rat-2 fibroblasts. EMBO J 12: 5161-5172.
13. Mancini A, Niedenthal R, Joos H, Koch A, Trouliaris S, et al. (1997) Identification of a second Grb2 binding site in the v-Fms tyrosine kinase. Oncogene 15: 1565-1572.
14. Kolch W, (2005) Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat Rev Mol Cell Biol 6: 827-837.
15. Reedijk M, Liu X, van der Geer P, Letwin K, Waterfield M, et al. (1992) Tyr721 regulates specific binding of the CSF-1 receptor kinase insert to PI 3′-kinase SH2 domains: a model for SH2-mediated receptor-target interactions. EMBO J 11: 1365-1372.
16. Lee AW-M, States DJ, (2000) Both Src-dependent and-independent mechanisms mediate phosphatidylinositol 3-kinase regulation of colony stimulating factor 1-activated mitogen-activated protein kinases in myeloid progenitors. Mol Cell Biol 20: 6779-6798.
17. Wilhelmsen K, Burkhalter S, van der Geer P, (2002) C-Cbl binds the CSF-1 receptor at tyrosine 973, a novel phosphorylation site in the receptor's carboxy-terminus. Oncogene 21: 1079-1089.
18. Lee PS, Wang Y, Dominguez M, Yeung Y, Murphy M, et al. (1999) The Cbl protooncoprotein stimulates CSF-1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation. EMBO J 18: 3616-3628.
19. Lee AW-M, (1999) Synergistic activation of mitogen-activated protein kinase by cyclic AMP and myeloid growth factors opposes cyclic AMP's growth-inhibitory effects. Blood 93: 537-553.
20. Trakul N, Menard RE, Schade GR, Qian Z, Rosner MR, (2005) Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation. J Biol Chem 280: 24931-24940.
21. Chang F, Steelman LS, Lee JT, Shelton JG, Navolanic PM, et al. (2003) Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia 17: 1263-1293.
22. Newton AC, (2010) Protein kinase C: poised to signal. Am J Physiol Endocrinol Metab 298: E395-402.
23. Schonwasser D, Marais R, Marshall CJ, Parker PJ, (1998) Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol Cell Biol 18: 790-798.
24. Berra E, Diaz-Meco MT, Lozano J, Frutos S, Municio MM, et al. (1995) Evidence for a role of MEK and MAPK during signal transduction by protein kinase Cζ. EMBO J 14: 6157-6163.
25. Martin P, Duran A, Minguet S, Gaspar M-L, Diaz-Meco M-T, et al. (2002) Role of zeta PKC in B-cell signaling and function. EMBO J 21: 4049-4057.
26. Chou M, Hou W, Johnson J, Graham L, Lee M, et al. (1998) Regulation of protein kinase C ζ by PI 3-kinase and PDK-1. Curr Biol 8: 1069-1077.
27. Junttila I, Bourette RP, Rohrschneider LR, Silvennoinen O, (2003) M-CSF induced differentiation of myeloid precursor cells involves activation of PKC-delta and expression of Pkare. J Leukoc Biol 73: 281-288.
28. Valledor AF, Xaus J, Marquès L, Celada A, (1999) Macrophage colony-stimulating factor induces the expression of mitogen-activated protein kinase phosphatase-1 through a protein kinase C-dependent pathway. J Immunol 163: 2452-2462.
29. Guo H, Ma Y, Zhang B, Sun B, Niu R, et al. (2009) Pivotal Advance: PKCzeta is required for migration of macrophages. J Leukoc Biol 85: 911-918.
30. Garcia-Paramio P, Cabrerizo Y, Bornancin F, Parker P, (1998) The broad specificity of dominant inhibitory protien kinase C mutants infers a common step in phosphorylation. Biochem J 333: 631-636.
31. Xu D, Wang S, Yu W-M, Chan G, Araki T, et al. (2010) A gain-of-function mutation in Ptpn11 (Shp-2) phosphatase induces myeloproliferative disease by aberrant activation of hematopoietic stem cells. Blood 116: 3611-3621.
32. Hobbs S, Jitrapakdee S, Wallace JC, (1998) Development of a bicistronic vector driven by the human polypeptide chain elongation factor 1alpha promoter for creation of stable mammalian cell lines that express very high levels of recombinant proteins. Biochem Biophys Res Commun 252: 368-372.
33. McDonald C, Chen FF, Ollendorff V, Ogura Y, Marchetto S, et al. (2005) A role for Erbin in the regulation of Nod2-dependent NF-kappaB signaling. J Biol Chem 280: 40301-40309.
34. Lee AW, States DJ, (2006) Colony-stimulating factor-1 requires PI3-kinase-mediated metabolism for proliferation and survival in myeloid cells. Cell Death Differ 13: 1900-1914.
35. de Bruijn MF, Slieker WA, van der Loo JC, Voerman JS, van Ewijk W, et al. (1994) Distinct mouse bone marrow macrophage precursors identified by differential expression of ER-MP12 and ER-MP20 antigens. Eur J Immunol 24: 2279-2284.
36. Martiny-Baron G, Kazanietz M, Mischak H, Blumberg P, Kochs G, et al. (1993) Selective inhibition of protein kinase C isozymes by the indolocarbazole Go6976. J Biol Chem 268: 9194-9197.
37. Gschwendt M, Dieterich S, Rennecke J, Kittstein W, Mueller HJ, et al. (1996) Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes. FEBS Lett 392: 77-80.
38. Davies SP, Reddy H, Caivano M, Cohen P, (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95-105.
39. Roberts NA, Marber MS, Avkiran M, (2004) Specificity of action of bisindolylmaleimide protein kinase C inhibitors: do they inhibit the 70 kDa ribosomal S6 kinase in cardiac myocytes? Biochem Pharmacol 68: 1923-1928.
40. Wooten MW, Zhou G, Seibenhener ML, Coleman ES, (1994) A role for zeta protein kinase C in nerve growth factor-induced differentiation of PC12 cells. Cell Growth Differ 5: 395-403.
41. Cohen EEW, Lingen MW, Zhu B, Zhu H, Straza MW, et al. (2006) Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase. Cancer Research 66: 6296-6303.
42. Chen J, Fujii K, Zhang L, Roberts T, Fu H, (2001) Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism. Proc Natl Acad Sci USA 98: 7783-7788.
43. Pearce LR, Komander D, Alessi DR, (2010) The nuts and bolts of AGC protein kinases. Nat Rev Mol Cell Biol 11: 9-22.
44. Bandyopadhyay G, Standaert M, Zhao L, Yu B, Avignon A, et al. (1997) Activation of protein kinase C (α, β and ζ) by insulin in 3T3/L1 cells. J Biol Chem 272: 2551-2558.
45. van Dijk CM, Muriana FJG, van der Hoeven PCJ, de Widt J, Schaap D, et al. (1997) Diacylglycerol generated by exogenous phospholipase C activates the mitogen-activated protein kinase pathway independent of Ras- and phorbol ester-sensitive protein kinase C: dependence on protein kinase C-zeta. Biochem J 323: 693-699.
46. Standaert M, Galloway L, Karnam P, Bandyopadhyay G, Moscat J, et al. (1997) Protein kinase C-ζ as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. J Biol Chem 272: 30075-30082.
47. Schönwasser DC, Marais RM, Marshall CJ, Parker PJ, (1998) Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol Cell Biol 18: 790-798.
48. Oeckinghaus A, Ghosh S, (2009) The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol 1: a000034.
49. Good JL, Ziegler W, Parekh D, Alessi D, Cohen P, et al. (1998) Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281: 2042-2045.
50. Diaz-Meco MT, Moscat J, (2001) MEK5, a new target of the atypical protein kinase C isoforms in mitogenic signaling. Mol Cell Biol 21: 1218-1227.
51. Shaul YD, Seger R, (2007) The MEK/ERK cascade: from signaling specificity to diverse functions. Biochim Biophys Acta 1773: 1213-1226.
52. Valledor A, Xaus J, Marques L, Celada A, (1999) Macrophage clony-stimulating factor induces the expression of mitogen-activated protein kinase phosphatase-1 through a protein kinase C-dependent pathway. J Immunol 163: 2452-2462.
53. McKay MM, Morrison DK, (2007) Integrating signals from RTKs to ERK/MAPK. Oncogene 26: 3113-3121.
54. Buscher D, Hipskind R, Krautwald S, Reimann T, Baccarini M, (1995) Ras-dependent and independent pathways target the mitogen-activated protein kinase network in macrophages. Mol Cell Biol 15: 466-475.
55. Moscat J, Diaz-Meco MT, (2011) Fine tuning NF-κB: new openings for PKC-ζ. Nat Immunol 12: 12-14.
56. Ito Y, Teitelbaum SL, Zou W, Zheng Y, Johnson JF, et al. (2010) Cdc42 regulates bone modeling and remodeling in mice by modulating RANKL/M-CSF signaling and osteoclast polarization. J Clin Invest 120: 1981-1993.
57. Lee M-C, Wei S-C, Tsai-Wu J-J, Wu CHH, Tsao P-N, (2008) Novel PKC signaling is required for LPS-induced soluble Flt-1 expression in macrophages. J Leukoc Biol 84: 835-841.
58. Hamdorf M, Berger A, Schule S, Reinhardt J, Flory E, (2011) PKCdelta-Induced PU.1 Phosphorylation Promotes Hematopoietic Stem Cell Differentiation to Dendritic Cells. Stem Cells 29: 297-306.